These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22459396)

  • 1. Early and mid-term cardiovascular outcomes following TAVI: impact of pre-procedural transvalvular gradient.
    Amabile N; Ramadan R; Ghostine S; Cheng S; Azmoun A; Raoux F; To NT; Haddouche Y; Troussier X; Nottin R; Caussin C
    Int J Cardiol; 2013 Aug; 167(3):687-92. PubMed ID: 22459396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of severe left ventricular systolic dysfunction on hospital outcome after transcatheter aortic valve implantation or surgical aortic valve replacement: results from a propensity-matched population of the Italian OBSERVANT multicenter study.
    Onorati F; D'Errigo P; Grossi C; Barbanti M; Ranucci M; Covello DR; Rosato S; Maraschini A; Santoro G; Tamburino C; Seccareccia F; Santini F; Menicanti L;
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):568-75. PubMed ID: 24263007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of low preprocedural transvalvular gradient on cardiovascular mortality following TAVI: an analysis from the FRANCE 2 registry.
    Amabile N; Agostini H; Gilard M; Eltchaninoff H; Iung B; Donzeau-Gouge P; Chevreul K; Fajadet J; Leprince P; Leguerrier A; Lievre M; Prat A; Teiger E; Laskar M; Caussin C
    EuroIntervention; 2014 Nov; 10(7):842-9. PubMed ID: 25415151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical presentation and outcomes after transcatheter aortic valve implantation in patients with low flow/low gradient severe aortic stenosis.
    Elhmidi Y; Piazza N; Krane M; Deutsch MA; Mazzitelli D; Lange R; Bleiziffer S
    Catheter Cardiovasc Interv; 2014 Aug; 84(2):283-90. PubMed ID: 24407885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A meta-analysis of mortality and major adverse cardiovascular and cerebrovascular events following transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis.
    Panchal HB; Ladia V; Desai S; Shah T; Ramu V
    Am J Cardiol; 2013 Sep; 112(6):850-60. PubMed ID: 23756547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor marker carbohydrate antigen 125 predicts adverse outcome after transcatheter aortic valve implantation.
    Husser O; Núñez J; Núñez E; Holzamer A; Camboni D; Luchner A; Sanchis J; Bodi V; Riegger GA; Schmid C; Hilker M; Hengstenberg C
    JACC Cardiovasc Interv; 2013 May; 6(5):487-96. PubMed ID: 23702013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of left ventricular systolic function on clinical and echocardiographic outcomes following transcatheter aortic valve implantation for severe aortic stenosis.
    Ewe SH; Ajmone Marsan N; Pepi M; Delgado V; Tamborini G; Muratori M; Ng AC; van der Kley F; de Weger A; Schalij MJ; Fusari M; Biglioli P; Bax JJ
    Am Heart J; 2010 Dec; 160(6):1113-20. PubMed ID: 21146666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of clinical outcomes in patients with severe aortic stenosis undergoing TAVI: a multistate analysis.
    Pilgrim T; Kalesan B; Wenaweser P; Huber C; Stortecky S; Buellesfeld L; Khattab AA; Eberle B; Gloekler S; Gsponer T; Meier B; Jüni P; Carrel T; Windecker S
    Circ Cardiovasc Interv; 2012 Dec; 5(6):856-61. PubMed ID: 23169986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence, predictors and prognostic value of serious hemorrhagic complications following transcatheter aortic valve implantation.
    Amabile N; Azmoun A; Ghostine S; Ramadan R; Haddouche Y; Raoux F; To NT; Troussier X; Nottin R; Caussin C
    Int J Cardiol; 2013 Sep; 168(1):151-6. PubMed ID: 23079085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesis.
    Ussia GP; Barbanti M; Petronio AS; Tarantini G; Ettori F; Colombo A; Violini R; Ramondo A; Santoro G; Klugmann S; Bedogni F; Maisano F; Marzocchi A; Poli A; De Carlo M; Napodano M; Fiorina C; De Marco F; Antoniucci D; de Cillis E; Capodanno D; Tamburino C;
    Eur Heart J; 2012 Apr; 33(8):969-76. PubMed ID: 22240494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A meta-analysis of mortality and major adverse cardiovascular and cerebrovascular events in patients undergoing transfemoral versus transapical transcatheter aortic valve implantation using edwards valve for severe aortic stenosis.
    Panchal HB; Ladia V; Amin P; Patel P; Veeranki SP; Albalbissi K; Paul T
    Am J Cardiol; 2014 Dec; 114(12):1882-90. PubMed ID: 25438917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes of patients with low-flow, low-gradient, severe aortic stenosis and either preserved or reduced ejection fraction undergoing transcatheter aortic valve implantation.
    O'Sullivan CJ; Stortecky S; Heg D; Pilgrim T; Hosek N; Buellesfeld L; Khattab AA; Nietlispach F; Moschovitis A; Zanchin T; Meier B; Windecker S; Wenaweser P
    Eur Heart J; 2013 Nov; 34(44):3437-50. PubMed ID: 24096324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-procedural hypertension following transcatheter aortic valve implantation: incidence and clinical significance.
    Perlman GY; Loncar S; Pollak A; Gilon D; Alcalai R; Planer D; Lotan C; Danenberg HD
    JACC Cardiovasc Interv; 2013 May; 6(5):472-8. PubMed ID: 23602460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of aortic valve calcification on the outcome of transcatheter aortic valve implantation: results from the prospective multicenter German TAVI registry.
    Staubach S; Franke J; Gerckens U; Schuler G; Zahn R; Eggebrecht H; Hambrecht R; Sack S; Richardt G; Horack M; Senges J; Steinberg DH; Ledwoch J; Fichtlscherer S; Doss M; Wunderlich N; Sievert H;
    Catheter Cardiovasc Interv; 2013 Feb; 81(2):348-55. PubMed ID: 22566406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early clinical outcome of aortic transcatheter valve-in-valve implantation in the Nordic countries.
    Ihlberg L; Nissen H; Nielsen NE; Rück A; Busund R; Klaarborg KE; Soendergaard L; Harnek J; Miettinen H; Eskola M; Wahba A; Laine M
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1047-54; discussion 1054. PubMed ID: 23998786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart failure in severe aortic valve stenosis: prognostic impact of left ventricular ejection fraction and mean gradient on outcome after transcatheter aortic valve implantation.
    Gotzmann M; Rahlmann P; Hehnen T; Müller P; Lindstaedt M; Mügge A; Ewers A
    Eur J Heart Fail; 2012 Oct; 14(10):1155-62. PubMed ID: 22782969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence, outcome and correlates of residual paravalvular aortic regurgitation after transcatheter aortic valve implantation and importance of haemodynamic assessment.
    Patsalis PC; Konorza TF; Al-Rashid F; Plicht B; Riebisch M; Wendt D; Thielmann M; Jakob H; Eggebrecht H; Heusch G; Erbel R; Kahlert P
    EuroIntervention; 2013 Apr; 8(12):1398-406. PubMed ID: 23256946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute kidney injury following transcatheter aortic valve implantation: incidence, predictors and clinical outcome.
    Saia F; Ciuca C; Taglieri N; Marrozzini C; Savini C; Bordoni B; Dall'Ara G; Moretti C; Pilato E; Martìn-Suàrez S; Petridis FD; Di Bartolomeo R; Branzi A; Marzocchi A
    Int J Cardiol; 2013 Sep; 168(2):1034-40. PubMed ID: 23164594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pro B-type natriuretic peptide plasma value: a new criterion for the prediction of short- and long-term outcomes after transcatheter aortic valve implantation.
    López-Otero D; Trillo-Nouche R; Gude F; Cid-Álvarez B; Ocaranza-Sanchez R; Alvarez MS; Lear PV; Gonzalez-Juanatey JR
    Int J Cardiol; 2013 Sep; 168(2):1264-8. PubMed ID: 23280329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of preprocedural assessment of myocardial contractility reserve on outcomes of aortic stenosis patients with impaired left ventricular function undergoing transcatheter aortic valve implantation.
    Barbash IM; Minha S; Ben-Dor I; Dvir D; Magalhaes MA; Torguson R; Okubagzi P; Satler LF; Pichard AD; Waksman R
    Am J Cardiol; 2014 May; 113(9):1536-42. PubMed ID: 24641965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.